La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
RAPT Therapeutics Gestione
Gestione criteri di controllo 2/4
Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.
Informazioni chiave
Brian Wong
Amministratore delegato
US$6.6m
Compenso totale
| Percentuale dello stipendio del CEO | 9.2% |
| Mandato del CEO | 9yrs |
| Proprietà del CEO | 1.4% |
| Durata media del management | 4.5yrs |
| Durata media del Consiglio di amministrazione | 7.3yrs |
Aggiornamenti recenti sulla gestione
Recent updates
RAPT: CCR4 Inhibition Presses On For Now With Oncology Focus
Jul 24Companies Like RAPT Therapeutics (NASDAQ:RAPT) Could Be Quite Risky
Jun 13
RAPT Therapeutics: Dip Following FDA Clinical Hold Creates Asymmetric Opportunity
May 20Is RAPT Therapeutics (NASDAQ:RAPT) In A Good Position To Invest In Growth?
Feb 21We Think RAPT Therapeutics (NASDAQ:RAPT) Can Afford To Drive Business Growth
Sep 12We Think RAPT Therapeutics (NASDAQ:RAPT) Can Afford To Drive Business Growth
May 10We're Hopeful That RAPT Therapeutics (NASDAQ:RAPT) Will Use Its Cash Wisely
Feb 07We're Hopeful That RAPT Therapeutics (NASDAQ:RAPT) Will Use Its Cash Wisely
Oct 12RAPT Therapeutics (NASDAQ:RAPT) Is In A Good Position To Deliver On Growth Plans
Jan 25RAPT Therapeutics (NASDAQ:RAPT) Is In A Good Position To Deliver On Growth Plans
Oct 15RAPT Therapeutics (RAPT) skyrockets 100% on positive RPT193 data in early-stage atopic dermatitis study
Jun 14RAPT Therapeutics (NASDAQ:RAPT) Is In A Good Position To Deliver On Growth Plans
Jun 08Should You Take Comfort From Insider Transactions At RAPT Therapeutics, Inc. (NASDAQ:RAPT)?
Mar 15We Think RAPT Therapeutics (NASDAQ:RAPT) Can Easily Afford To Drive Business Growth
Feb 15
RAPT Therapeutics' (NASDAQ:RAPT) Stock Price Has Reduced 56% In The Past Year
Jan 18RAPT Therapeutics: Interesting Asset, But Doubtful History And Bad Market Reaction
Jan 08Here's What RAPT Therapeutics, Inc.'s (NASDAQ:RAPT) Shareholder Ownership Structure Looks Like
Dec 21The Independent Chairman of the Board of RAPT Therapeutics, Inc. (NASDAQ:RAPT), William Rieflin, Just Bought 12% More Shares
Nov 23Earnings Beat: RAPT Therapeutics, Inc. (NASDAQ:RAPT) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
Nov 19RAPT Therapeutics tumbles 25% despite promising FLX475 data in multiple cancers
Nov 16Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$120m |
| Mar 31 2024 | n/a | n/a | -US$118m |
| Dec 31 2023 | US$7m | US$605k | -US$117m |
| Sep 30 2023 | n/a | n/a | -US$109m |
| Jun 30 2023 | n/a | n/a | -US$99m |
| Mar 31 2023 | n/a | n/a | -US$93m |
| Dec 31 2022 | US$5m | US$580k | -US$84m |
| Sep 30 2022 | n/a | n/a | -US$79m |
| Jun 30 2022 | n/a | n/a | -US$76m |
| Mar 31 2022 | n/a | n/a | -US$73m |
| Dec 31 2021 | US$3m | US$540k | -US$69m |
| Sep 30 2021 | n/a | n/a | -US$64m |
| Jun 30 2021 | n/a | n/a | -US$60m |
| Mar 31 2021 | n/a | n/a | -US$56m |
| Dec 31 2020 | US$4m | US$500k | -US$53m |
| Sep 30 2020 | n/a | n/a | -US$53m |
| Jun 30 2020 | n/a | n/a | -US$49m |
| Mar 31 2020 | n/a | n/a | -US$47m |
| Dec 31 2019 | US$2m | US$447k | -US$43m |
| Sep 30 2019 | n/a | n/a | -US$39m |
| Jun 30 2019 | n/a | n/a | -US$40m |
| Mar 31 2019 | n/a | n/a | -US$37m |
| Dec 31 2018 | US$1m | US$425k | -US$36m |
Compensazione vs Mercato: La retribuzione totale di Brian ($USD 6.59M ) è superiore alla media delle aziende di dimensioni simili nel mercato US ($USD 681.57K ).
Compensazione vs guadagni: La retribuzione di Brian è aumentata nonostante l'azienda non sia redditizia.
AMMINISTRATORE DELEGATO
Brian Wong (52 yo)
9yrs
Mandato
US$6,591,617
Compensazione
Dr. Brian Russell Wong, M.D., Ph.D. serves as Venture Partner at The Column Group, LLC since joining the firm in 2022. He has been Chief Executive Officer and Director at RAPT Therapeutics, Inc. since Augu...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO, President & Director | 9yrs | US$6.59m | 1.41% $ 1.1m | |
| CFO, Principal Accounting Officer & Secretary | 4.7yrs | US$2.18m | 0.034% $ 27.2k | |
| Chief Medical Officer | 9.3yrs | US$1.90m | 0.045% $ 36.5k | |
| Vice President of Technology | no data | Nessun dato | Nessun dato | |
| Chief Scientific Officer | 5.2yrs | US$1.48m | 0.074% $ 59.9k | |
| General Counsel | 1.6yrs | Nessun dato | Nessun dato | |
| Chief Human Resources Officer | 2.3yrs | Nessun dato | Nessun dato | |
| Senior Vice President of Quantitative & Computational Biology | 4.4yrs | Nessun dato | Nessun dato | |
| Senior Vice President of Drug Discovery & Preclinical Development | 5.6yrs | Nessun dato | Nessun dato | |
| Senior Vice President of Regulatory Affairs & Quality Assurance | 1.9yrs | Nessun dato | Nessun dato | |
| Senior Vice President of Technical Operations | less than a year | Nessun dato | Nessun dato |
4.5yrs
Durata media
57.5yo
Età media
Gestione esperta: Il team dirigenziale di RAPT è considerato esperto (durata media dell'incarico 4.5 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO, President & Director | 9yrs | US$6.59m | 1.41% $ 1.1m | |
| Independent Chairman of the Board | 9.3yrs | US$300.28k | 0.27% $ 219.8k | |
| Independent Director | 4.7yrs | US$277.78k | 0% $ 0 | |
| Member of Scientific Advisory Board | 7.3yrs | Nessun dato | Nessun dato | |
| Member of Scientific Advisory Board | 7.3yrs | Nessun dato | Nessun dato | |
| Chairman of Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
| Member of Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
| Member of Scientific Advisory Board | 6.9yrs | Nessun dato | Nessun dato | |
| Member of Scientific Advisory Board | 5.1yrs | Nessun dato | Nessun dato | |
| Independent Director | 6.6yrs | US$267.78k | 0% $ 0 | |
| Independent Director | 7.7yrs | US$260.78k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | Nessun dato | Nessun dato |
7.3yrs
Durata media
65yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di RAPT sono considerati esperti (durata media dell'incarico 7.3 anni).